You have 9 free searches left this month | for more free features.

IFNβ-1b

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)

Recruiting
  • Solid Tumor
  • +2 more
  • VSV-IFNβ-NIS
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic
Sep 26, 2022

COVID-19 Virus Infection Trial in Milano (Interferon-ß-1a, Standard of Care (SOC))

Terminated
  • COVID-19 Virus Infection
  • Milano, Italy
    IRCCS Ospedale San Raffaele
Apr 28, 2021

Biospecimen in Pediatric Patients and Adult Guardians Diagnosed

Recruiting
  • Glycogen Storage Disease Type IB
  • Specimen Donation
  • Woburn, Massachusetts
    Sanguine BioSciences, Inc.
Jun 22, 2023

Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Relapsed/Refractory Large B-cell Lymphoma
  • (no location specified)
Oct 6, 2023

Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

Not yet recruiting
  • Pulmonary Sarcoidosis
  • XTMAB-16 or Placebo
  • (no location specified)
May 25, 2023

Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

Recruiting
  • Chronic Inducible Urticaria
  • Oral EP262
  • Tampa, Florida
  • +5 more
Sep 18, 2023

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 27, 2023

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023

Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)

Not yet recruiting
  • Decompensated Cirrhosis
  • Human Umbilical Cord-derived Mesenchymal Stem Cells
  • Beijing, China
    Beijing 302 Hospital
Aug 2, 2023

Leprosy Trial in Rio de Janeiro (LEP-F1 + GLA-SE, Placebo)

Not yet recruiting
  • Leprosy
  • LEP-F1 + GLA-SE
  • Placebo
  • Rio de Janeiro, Brazil
    Veronica Schmitz Pereira
Dec 5, 2022

Diabetes, Type 1 Trial in Valencia (Aerobic, High-intensity interval training)

Completed
  • Diabetes Mellitus, Type 1
  • Aerobic
  • High-intensity interval training
  • Valencia, Spain
    Rodrigo Martin-San Agustin
Oct 17, 2023

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

Recruiting
  • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
  • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
  • ELISA and colorimeter
  • Assiut, Egypt
    Biochemistry department,Faculty of medicine
Oct 10, 2023

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting
  • Metastatic Myxoid Liposarcoma
  • +15 more
  • Interferon Gamma-1b
  • +2 more
  • Palo Alto, California
  • +6 more
Aug 2, 2022

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

Recruiting
  • Chronic Hepatitis B
  • VRON-0200-AdC6
  • VRON-0200-AdC7
  • Hong Kong, Hong Kong
  • +1 more
Oct 6, 2023

Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

Active, not recruiting
  • Alcohol Use Disorder
  • Glendale, California
    Parexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023

Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)

Completed
  • Cancer
  • Neoplasm
  • NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
  • Frankfurt, Germany
    Krankenhaus Nordwest
Oct 3, 2022

Squamous Cell Carcinoma, RP1 Trial (RP1)

Not yet recruiting
  • Squamous Cell Carcinoma
  • RP1
  • (no location specified)
May 4, 2023

Advanced Solid Tumor Trial (NB002)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 29, 2023

NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 16, 2023

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Whittier, California
    New Hope Research Development
Feb 15, 2023